Frontlight ResearchEarly access
Trial site
Mid Hudson Medical Research
- 3running trials
- 9closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease5 trials
- Type 2 diabetes3 trials
- Colorectal cancer2 trials
- Mild cognitive impairment2 trials
- Obesity2 trials
- Chronic kidney disease1 trial
- Diabetic neuropathy1 trial
- Familial hypercholesterolaemia1 trial
- Lung cancer1 trial
- Lyme disease1 trial
- Obstructive sleep apnoea1 trial
- Pancreatic cancer1 trial
- and 1 more
- Phase
- Phase 37 trials
- Phase 22 trials
- Status
- Completed8 trials
- Recruiting2 trials
- Enrolling by invitation1 trial
- Suspended1 trial
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company4 trials
- Cassava Sciences, Inc.2 trials
- Cognito Therapeutics, Inc.2 trials
- Celgene1 trial
- NewAmsterdam Pharma1 trial
- and 3 more
Running trials
Recruiting
Enrolling by invitation
Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease2 recruiting
- Colorectal cancer1 recruiting
- Mild cognitive impairment1 recruiting
Closed trials
Completed
Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy
Completed
Completed
Completed
Completed
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
Terminated
Open-label Extension for Phase 3 Clinical Trials of Simufilam
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026